Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Automatic oxygen titration with O2matic® to patients admitted with COVID-19 and hypoxemic respiratory failure

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The Danish severe asthma register: an electronic platform for severe asthma management and research

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Disease self-management in patients with moderate COPD: a thematic analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Guideline for the management of COVID-19 patients during hospital admission in a non-intensive care setting

    Research output: Contribution to journalReviewResearchpeer-review

  4. Clinical and daily respiratory care and clinical trials within the COVID-19 era

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Clinical characteristics of the BREATHE cohort - a real-life study on patients with asthma and COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Introduction: Patients with coronavirus disease (COVID-19) and pneumonitis often have hypoxemic respiratory failure and a need of supplementary oxygen. Guidelines recommend controlled oxygen, for most patients with a recommended interval of SpO2 between 92 and 96%. We aimed to determine if closed-loop control of oxygen was feasible in patients with COVID-19 and could maintain SpO2 in the specified interval.

Methods: Patients were prospectively enrolled in an observational study on a medical ward dedicated to patients with COVID-19. Closed-loop controlled oxygen was delivered by O2matic® which can deliver 0-15 liters/min and adjusts flow every second based on 15 seconds averaging of SpO2 measured by pulse oximetry. Lung function parameters were measured at admission.

Results: Fifteen patients (six women, nine men) participated in the study. Average age was 72 years. Lung function was severely impaired with FEV1, FVC and PEF reduced to approximately 50%. The average stay on the ward was 3.2 days and O2matic was used on average for 66 hours, providing 987 hours of observation. O2matic maintained SpO2 in the desired interval for 82.9% of the time. Time with SpO2 > 2% below interval was 5.1% and time with SpO2 > 2% above interval was 0.6%.

Conclusion: Closed-loop control of oxygen to patients with COVID-19 is feasible and can maintain SpO2 in the specified interval in the majority of time. Closed-loop automated control could be of particular benefit for patients in isolation with decreased visibility, surveillance and monitoring. Further studies must examine the clinical benefits.

Original languageEnglish
JournalEuropean Clinical Respiratory Journal
Volume7
Issue number1
Pages (from-to)1833695
ISSN2001-8525
DOIs
Publication statusPublished - 14 Oct 2020

ID: 61235043